Homer Pearce

Board Executive at Apexian Pharmaceuticals

Homer served in various capacities at Eli Lilly & Company after joining the company in 1979, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. He was involved in the development of more than 25 investigational drugs, of which three have resulted in regulatory approvals, including Gemzar® and Alimta®.

Homer was recently named “A Hero of Chemistry” by the American Chemical Society for his role in the discovery and development of the anti-cancer drug Alimta. Homer earned his doctoral degree from Harvard University with Nobel Laureate, E. J. Corey and his bachelor’s degree from Texas A&M University. He is a member of the American Association for Cancer Research, the American Chemical Society and the American Association for the Advancement of Science. He currently serves on several advisory and company boards.